Company announcements · 28/10/20261 min read
Transpharmation Ltd. announces the strategic acquisition of OrganoTherapeutics SARL
Summary
TORONTO, Oct. 28, 2026 — Transpharmation Ltd., a science-led global leader in neuroscience, pain and metabolic disease preclinical contract research, is pleased to announce its acquisition of...